海量图书期刊资源,随时随地畅享阅读乐趣
Phosphoinositide 3-Kinase Mutations in Breast Cancer: A "Good" Activating Mutation?Di Cosimo, S.; Baselga, J. · Clinical Cancer Research · 2009
4005 Trastuzumab-related cardiotoxicity in the elderly: which role for cardiovascular risk factors?C. Serrano; J. Cortés; M. Russillo; M. Bellet; P. Gómez; C. Saura; J. Pérez; M.J. Carreras; J. Baselga; S. Di Cosimo · 2009
4012 Adjuvant docetaxel and cyclofosfamide in breast cancer patients over 65 years: compliance and toxicityC. Serrano; J. Cortés; M. Russillo; M. Bellet; P. Gómez; C. Saura; J. Pérez; A. Farriols; J. Baselga; S. Di Cosimo · 2009
5064 POSTER Breast Cancer Subtype and Survival in Metastatic Patients Treated With BevacizumabCastro, D. Torrejon; Di Cosimo, S.; Vidal, M.; Gomez, P.; Bellet, M.; Saura, C.; Perez-Garcia, J.; Mufioz, E.; Baselga, J.; Cortes, J. · European Journal of Cancer · 2011
Combination of the mTOR Inhibitor Ridaforolimus and the Anti-IGF1R Monoclonal Antibody Dalotuzumab: Preclinical Characterization and Phase I Clinical TrialDi Cosimo, S.; Sathyanarayanan, S.; Bendell, J. C.; Cervantes, A.; Stein, M. N.; Brana, I.; Roda, D.; Haines, B. B.; Zhang, T.; Winter, C. G.; Jha, S.; Xu, Y.; Frazier, J.; Klinghoffer, R. A.; Leighton-Swayze, A.; Song, Y.; Ebbinghaus, S.; Baselga, J. · Clinical Cancer Research · 2015
Nonpegylated Liposomal Doxorubicin (TLC-D99), Paclitaxel, and Trastuzumab in HER-2-Overexpressing Breast Cancer: A Multicenter Phase I/II StudyCortes, J.; Di Cosimo, S.; Climent, M. A.; Cortes-Funes, H.; Lluch, A.; Gascon, P.; Mayordomo, J. I.; Gil, M.; Benavides, M.; Cirera, L.; Ojeda, B.; Rodriguez, C. A.; Trigo, J. M.; Vazquez, J.; Regueiro, P.; Dorado, J. F.; Baselga, J. · Clinical Cancer Research · 2009
breast cancer, early stageMok, T. S. K.; Paz-Ares, L.; Wu, Y.-L.; Novello, S.; Juhasz, E.; Aren, O.; Sun, Y.; Hirsh, V.; Smit, E. F.; Lathia, C.; Ong, T. J.; Pena, C.; Pivot, X.; Romieu, G.; Bonnefoi, H.; Pierga, J.-Y.; Kerbrat, P.; Guastalla, J.-P.; Lortholary, A.; Espie, M.; Fumoleau, P.; Serin, D.; Jacquin, J.-P.; Jouannaud, C.; Rios, M.; Abadie-Lacourtoisie, S.; Tubiana-Mathieu, N.; Cany, L.; Catala, S.; Khayat, D.; Pauporte, I.; Kramar, A.; Goldhirsch, A.; Piccart, M.; Procter, M.; De Azambuja, E.; Weber, H.; Untch, M.; Smith, I. E.; Gianni, L.; Jackisch, C.; Cameron, D.; Bell, R.; Dowsett, M.; Gelber, R. D.; Leyland-Jones, B.; Baselga, J.; Baum, M.; Vaidya, J. S.; Bulsara, M. K.; Wenz, F.; Tobias, J. S.; Eiermann, W.; Joseph, D.; Pierga, J.; Asselain, B.; Alsafadi, S.; Brain, E.; Lerebours, F.; Delaloge, S.; Gentien, D.; Servant, N.; Sigal-Zafrani, B.; Andre, F.; Criscitiello, C.; Azim, H. A.; Agbor-Tarh, D.; De Azambuja, E.; Piccart, M.; Baselga, J.; Eidtmann, H.; Di Cosimo, S.; Bradbury, I.; Rubio, I. T.; Pivot, X.; Semiglazov, V.; Zurawski, B.; Allerton, R.; Fabi, A.; Ciruelos, E.; Parikh, R.; DeSilvio, M.; Santillana, S.; Swaby, R.; Verma, S.; Miles, D.; Gianni, L.; Krop, I.; Welslau, M.; Baselga, J.; Pegram, M.; Oh, D.; Dieras, V.; Guardino, E.; Fang, L.; Lu, M. W.; Olsen, S.; Blackwell, K.; Andre, F.; Bachelot, T.; Campone, M.; Ballester, M. A.; Commo, F.; Goncalves, A.; Levy, C.; Ferrero, J.; Lacroix, L.; Dieras, V.; Dalenc, F.; Gentien, D.; Lacroix, M.; Wang, Q.; Adelaide, J.; Jimenez, M.; Bonnefoi, H.; Heery, C.; Ibrahim, N.; Madan, R. A.; Mohebtash, M.; Arlen, P.; McMahon, S.; Hodge, S.; Steinberg, S. M.; Schlom, J.; Gulley, J. L.; Chauffert, B.; Feuvret, L.; Bonnetain, F.; Taillandier, L.; Frappaz, D.; Honnorat, J.; Fabbro, M.; Frenay, M.; Durando, X.; Tennevet, I.; Guillamo, J. S.; Tailla, H.; Schott, R.; Ghiringhelli, F.; Campello, C.; Tubiana-Mathieu, N.; Dalban, C.; Skrzypski, J.; Chinot, O.; Tabouret, E.; Boudouresque, F.; Barrie, M.; Matta, M.; Boucard, C.; Loundou, A · Annals of Oncology · 2012
Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy.Kattan, J; Culine, S; Terrier-Lacombe, M J; Theodore, C; Droz, J P · Annals of oncology : official journal of the European Society for Medical Oncology / ESMO · 1993
Combination immunotherapy approachesDrake, C. G. · Annals of Oncology · 2012
Advances in immuno-oncologyEggermont, A.; Finn, O. · Annals of Oncology · 2012
Thanks to referees 2011Annals of Oncology · 2012
OsteosarcomaRitter, J.; Bielack, S. S. · Annals of Oncology · 2010
The role of chemotherapy in cholangiocarcinomaThongprasert, S. · Annals of Oncology · 2005
Spirituality in the cancer trajectoryPuchalski, C. M. · Annals of Oncology · 2012
New insights into pancreatic cancer biologyHidalgo, M. · Annals of Oncology · 2012